Aflac has released a children's book, the proceeds of which will support youth affected by cancer and sickle cell disease.

Pyrukynd, which Agios sells for a rare type of anemia, missed one of its main objectives in a study seen as crucial for its ...

Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a ...

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) ranks among the most oversold biotech stocks to invest in. On November 20, Leerink ...

In its mission to grow the reach of its pyruvate kinase (PK) activator Pyrukynd (mitapivat), Agios Pharmaceuticals has come up short of producing an unequivocal win in the key indication of sickle | ...

Pain is a constant, complex companion that clinicians often struggle to understand and measure for people living with sickle ...

Having endured an impoverished childhood and bare-bones sickle cell care, Edward ‘Donnell’ Ivy, MD, devotes his career to ...

The NDDC launches a sickle cell awareness campaign in Delta, providing medical support, drugs, and education to patients and ...